Li-Zhe Wang Selected Research

Doxorubicin (Adriamycin)

5/2014

Single-agent cisplatin treatment of children with high-risk hepatoblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li-Zhe Wang Research Topics

Disease

2	Neoplasm Metastasis (Metastasis) 12/2019 - 05/2014
2	Hepatoblastoma 05/2014 - 07/2013
1	Disease Progression 01/2022
1	Precocious Puberty 01/2022
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2022
1	Pathologic Processes 01/2022
1	Breast Neoplasms (Breast Cancer) 12/2019
1	Osteosarcoma (Osteogenic Sarcoma) 12/2019
1	Heart Failure 05/2014
1	Neuroblastoma 02/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2012

Drug/Important Bio-Agent (IBA)

2	Cisplatin (Platino)FDA LinkGeneric 12/2019 - 05/2014
1	indolepropanol phosphate (IPP)IBA 01/2022
1	GonadotropinsIBA 01/2022
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2022
1	Therapeutic UsesIBA 12/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2014
1	Vincristine (Oncovin)FDA LinkGeneric 02/2014
1	Topotecan (Hycamtin)FDA LinkGeneric 02/2014
1	Irinotecan (Camptosar)FDA LinkGeneric 07/2013
1	Rituximab (Mabthera)FDA Link 05/2012

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 12/2019 - 05/2012
1	Therapeutics 01/2022
1	APO protocol 2 01/2022
1	Radiotherapy 12/2019
1	Neoadjuvant Therapy 05/2014